This conclusion is in line with the results of Dekker et al. [19] who observed that in patients with MS who lacked HLA-DQB1*06:02 allele, the HLA-DPB1*03:01 allele frequency was significantly (p = 0.006) increased (50.0%) compared with HLA-DQB1*06:02-negative controls (9.1%). This evidence concerns the gene HLA-DPB1 and myeloid sarcoma.